Evidence map›Paper›PMID 23104156›Full record

ArticleBiomedical microdevices2013

Proliferation and migration of tumor cells in tapered channels.

Yuan Wan, Deepika Tamuly, Peter B Allen, Young-Tae Kim, Robert Bachoo, Andrew D Ellington, Samir M Iqbal

Open access · greenAbstract read
In one paragraph

Article in Biomedical microdevices, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Quantitative cell imaging approaches to metastatic state profiling.Frontiers in cell and developmental biology · 2022
    Review
  4. A comparative assessment ofRSC advances · 2021
    Article
  5. Review
  6. Review
  7. The Concept of Making On-Chip Thermal Cycler for RT-PCR Using Conjugate Heat Transfer in Diverging Microchannel.Transactions of the Indian National Academy of Engineering : an international journal of engineering and technology · 2020
    Article
  8. Article
  9. Article
  10. Review
  11. GdSpectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2017
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Yuan WanNano-Bio Lab, University of Texas at Arlington, 500 S. Cooper St, M.S. 19072, Room #217, Arlington, TX, 76019, USA.
Deepika TamulyDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, 76019, USA.
Peter B AllenInstitute for Cell and Molecular Biology, University of Texas at Austin, Austin, TX, USA.
Young-Tae KimDepartment of Bioengineering, University of Texas at Arlington, Arlington, TX, 76019, USA.
Robert BachooAnnette G. Strauss Center for Neuro-Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Andrew D EllingtonInstitute for Cell and Molecular Biology, University of Texas at Austin, Austin, TX, USA.
Samir M IqbalNano-Bio Lab, University of Texas at Arlington, 500 S. Cooper St, M.S. 19072, Room #217, Arlington, TX, 76019, USA. smiqbal@uta.edu.
The University of Texas at Arlington · USThe University of Texas at Austin · USCenter for Neuro-Oncology · US

Funding

Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle ConjugateR01CA119388 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HASAN, TAYYABA · 2005 to 2009
$2.6M
Amorphous computation with transcription logic gatesR01GM094933 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI ELLINGTON, ANDREW D · 2010 to 2013
$1.2M
Directed evolution of RNA ligases for high-throughput sequencingR21HG005763 · NHGRI · UNIVERSITY OF TEXAS AT AUSTIN · PI ELLINGTON, ANDREW D · 2010 to 2011
$448k
Enzyme Bioreactor for Optimized Production of Modified Nucleic AcidsF32GM095280 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI ALLEN, PETER B · 2010 to 2011
$99k
NCI NIH HHS 5R01CA119388-05NCI NIH HHS R01 CA119388NHGRI NIH HHS 1-R21-HG00576301NHGRI NIH HHS R21 HG005763NIGMS NIH HHS F32 GM095280NIGMS NIH HHS GM095280NIGMS NIH HHS R01 GM094933
6 · The paper itself

Abstract

Tumor cells depict two deviant tendencies; over-proliferation and vigorous migration. A tapered channel device is designed and fabricated for in vitro studies. We report inhibited proliferation and migration of human glioblastoma (hGBM) cells when exposed to an aptamer that is known to bind epidermal growth factor receptors (EGFR). The device is integrated with controlled ambient and microscope for providing real-time and quantitative characterization of the tumor cell behavior. The results show that hGBM cells loose proliferation and motility when exposed to the anti-EGFR aptamer. The aptamer directly inhibits and blocks EGF-induced EGFR phosphorylation. This also reduces the ability of cells to remodel their internal structure for invasion through narrow constrictions. This provides a framework for possible studies on efficacy of other inhibiting molecules.

Indexed as

Cell MovementAptamers, NucleotideBiomimeticsCell DivisionCell ProliferationErbB ReceptorsGlioblastomaHumansMicrofluidic Analytical TechniquesPhosphorylationSignal TransductionAptamers, NucleotideEGFR protein, humanErbB Receptors

Identifiers

PMID23104156
PMCPMC3578089
OpenAlexW2033999514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.